z-logo
open-access-imgOpen Access
Pediatric Migraine
Author(s) -
Ubaid Hameed Shah,
Veena Kalra
Publication year - 2009
Publication title -
international journal of pediatrics
Language(s) - English
Resource type - Journals
eISSN - 1687-9759
pISSN - 1687-9740
DOI - 10.1155/2009/424192
Subject(s) - medicine , migraine , headaches , etiology , intensive care medicine , clinical trial , epilepsy , pediatrics , anesthesia , psychiatry
Migraine is the most common cause of acute recurrent headaches in children. The pathophysiological concepts have evolved from a purely vascular etiology to a neuroinflammatory process. Clinical evaluation is the mainstay of diagnosis and should also include family history. Investigations help to rule out secondary causes. The role of new drugs in treatment of migraine is discussed and trials are quoted from literature. Indications for starting prophylaxis should be evaluated based on frequency of attacks and influence on quality of life. For management of acute attacks of migraine both acetaminophen and ibuprofen are recommended for use in children. Many drugs like antiepileptic drugs (AED), calcium channel blockers, and antidepressants have been used for prophylaxis of migraine in children. The data for use of newer drugs for migraine in children is limited, though AEDs are emerging a popular choice. Biofeedback and other nonmedicinal therapies are being used with promising results.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom